Your browser doesn't support javascript.
loading
A Hoechst Reporter Enables Visualization of Drug Engagement In Vitro and In Vivo: Toward Safe and Effective Nanodrug Delivery.
Miyazaki, Takuya; Chen, Shaoyi; Florinas, Stelios; Igarashi, Kazunori; Matsumoto, Yu; Yamasoba, Tatsuya; Xu, Ze-Qi; Wu, Herren; Gao, Changshou; Kataoka, Kazunori; Christie, R James; Cabral, Horacio.
Afiliação
  • Miyazaki T; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Chen S; Kanagawa Institute of Industrial Science and Technology (KISTEC), 705-1 Shimoimaizumi, Ebina, Kanagawa 243-0435, Japan.
  • Florinas S; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Igarashi K; Antibody Discovery and Protein Engineering, AstraZeneca R&D, 1 MedImmune Way, Gaithersburg, Maryland 20878, United States.
  • Matsumoto Y; Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Yamasoba T; Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Xu ZQ; Department of Otorhinolaryngology and Head and Neck Surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Wu H; SynChem, Inc., Elk Grove Village, Illinois 60007, United States.
  • Gao C; Antibody Discovery and Protein Engineering, AstraZeneca R&D, 1 MedImmune Way, Gaithersburg, Maryland 20878, United States.
  • Kataoka K; Antibody Discovery and Protein Engineering, AstraZeneca R&D, 1 MedImmune Way, Gaithersburg, Maryland 20878, United States.
  • Christie RJ; Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan.
  • Cabral H; Antibody Discovery and Protein Engineering, AstraZeneca R&D, 1 MedImmune Way, Gaithersburg, Maryland 20878, United States.
ACS Nano ; 16(8): 12290-12304, 2022 08 23.
Article em En | MEDLINE | ID: mdl-35942986
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Imunoconjugados / Nanopartículas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: ACS Nano Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Imunoconjugados / Nanopartículas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: ACS Nano Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão